Goldman Sachs’s Epizyme, Inc EPZM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-2,629,998
Closed -$3.87M 5927
2022
Q2
$3.87M Sell
2,629,998
-3,112,142
-54% -$4.57M ﹤0.01% 2890
2022
Q1
$6.6M Buy
5,742,140
+2,479,597
+76% +$2.85M ﹤0.01% 2583
2021
Q4
$8.16M Buy
3,262,543
+2,690,437
+470% +$6.73M ﹤0.01% 2437
2021
Q3
$2.93M Buy
572,106
+19,764
+4% +$101K ﹤0.01% 3192
2021
Q2
$4.59M Sell
552,342
-159,618
-22% -$1.33M ﹤0.01% 2846
2021
Q1
$6.2M Buy
711,960
+85,781
+14% +$747K ﹤0.01% 2518
2020
Q4
$6.8M Buy
626,179
+75,847
+14% +$824K ﹤0.01% 2286
2020
Q3
$6.57M Sell
550,332
-79,336
-13% -$947K ﹤0.01% 2224
2020
Q2
$10.1M Buy
629,668
+188,840
+43% +$3.03M ﹤0.01% 1939
2020
Q1
$6.84M Sell
440,828
-43,483
-9% -$674K ﹤0.01% 2046
2019
Q4
$11.9M Sell
484,311
-69,264
-13% -$1.7M ﹤0.01% 1944
2019
Q3
$5.71M Buy
553,575
+83,642
+18% +$863K ﹤0.01% 2233
2019
Q2
$5.9M Buy
469,933
+58,153
+14% +$730K ﹤0.01% 2222
2019
Q1
$5.1M Buy
411,780
+245,700
+148% +$3.04M ﹤0.01% 2419
2018
Q4
$1.02M Buy
166,080
+27,820
+20% +$171K ﹤0.01% 3118
2018
Q3
$1.47M Buy
138,260
+24,528
+22% +$260K ﹤0.01% 3009
2018
Q2
$1.54M Sell
113,732
-8,249
-7% -$112K ﹤0.01% 2996
2018
Q1
$2.17M Sell
121,981
-10,129
-8% -$180K ﹤0.01% 2835
2017
Q4
$1.66M Sell
132,110
-93,592
-41% -$1.17M ﹤0.01% 2914
2017
Q3
$4.3M Buy
225,702
+124,033
+122% +$2.36M ﹤0.01% 2455
2017
Q2
$1.54M Buy
101,669
+52,738
+108% +$796K ﹤0.01% 2942
2017
Q1
$839K Sell
48,931
-4,451
-8% -$76.3K ﹤0.01% 3209
2016
Q4
$646K Buy
53,382
+30,061
+129% +$364K ﹤0.01% 3308
2016
Q3
$229K Buy
23,321
+7,241
+45% +$71.1K ﹤0.01% 3847
2016
Q2
$165K Buy
16,080
+871
+6% +$8.94K ﹤0.01% 3940
2016
Q1
$184K Buy
+15,209
New +$184K ﹤0.01% 3805
2015
Q4
Sell
-81,910
Closed -$1.05M 4666
2015
Q3
$1.05M Sell
81,910
-127,503
-61% -$1.64M ﹤0.01% 2888
2015
Q2
$5.03M Buy
209,413
+197,810
+1,705% +$4.75M ﹤0.01% 2072
2015
Q1
$218K Sell
11,603
-16,024
-58% -$301K ﹤0.01% 3848
2014
Q4
$521K Buy
27,627
+15,373
+125% +$290K ﹤0.01% 3342
2014
Q3
$332K Buy
12,254
+5,094
+71% +$138K ﹤0.01% 3590
2014
Q2
$223K Buy
+7,160
New +$223K ﹤0.01% 3906